Specialized Center of Research Program (SCOR) supports interdisciplinary investigator teams pursuing integrated blood cancer research to move laboratory discoveries toward clinical use.
Translational Research Program (TRP) supports independent investigators pursuing translational blood cancer research to move promising discoveries toward clinical use and address high unmet need.
Scholar in Clinical Research: Career Development Program (CDP) 2026–2027 supports clinical investigators’ salaries to advance patient-involved research on blood cancer prevention, diagnosis, or treatment.
Scholar – Career Development Program (CDP) 2026–2027 supports independent basic and translational investigators with salary support to sustain blood cancer research and advance their academic careers.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
Fellow, Career Development Program (CDP) 2026–2027 supports early-stage postdoctoral researchers with salary funding for mentored blood cancer research to advance understanding, diagnosis, treatment, and prevention.